Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Clinical trial NCT06233162 · UNKNOWN

Trial details

NCT number: NCT06233162
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-09-03
Primary completion: 2024-10-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.